NFKB1 and familial dilated cardiomyopathy: The results indicate that apigenin treatment reduces DCM by blocking the translocation of NF-κB, decreasing the amount of MDA and TNF-α, and boosting the levels of SOD and GPx in the left ventricular tissue [133].